Eltek (ELTK) Q4 2024 earnings summary

Executive summary

• 2024 revenue was $46.5 million, flat year-over-year and below expectations due to operational challenges, regional conflict, and facility upgrades impacting equipment installation and technical support.

• Net profit for 2024 was $4.2 million, down from $6.4 million in 2023, with a strong cash position after significant capital expenditures.

• Q4 2024 revenue was $10.8 million, compared to $12.3 million in Q4 2023; Q4 net profit was $0.

• Demand remains robust across defense, medical, and high-end industrial segments, with increased activity in defense tenders and industrial sectors.

• A $15 million investment plan is underway to expand manufacturing capacity and technology, targeting $55–$65 million in annual production.

Financial highlights

• 2024 revenue: $46.5 million vs. $46.7 million in 2023.

• Gross profit: $10.3 million (22% margin) vs. $13.1 million (28% margin) in 2023, mainly due to higher labor costs and product mix.

• Operating profit: $4.4 million vs. $7.3 million in 2023.

• Net profit: $4.2 million ($0.63/share) vs. $6.4 million ($1.07/share) in 2023.

• EBITDA: $5.9 million (13% margin) vs. $8.6 million (18% margin) in 2023.

• Positive operating cash flow: $4.5 million vs. $8.9 million in 2023.

• Q4 2024 EBITDA was $0.8 million (7% margin), compared to $2.4 million (19%) in Q4 2023.

Outlook and guidance

• Gross margin is expected to recover to 26%-29% over the next 2-3 years, following operational improvements and a more favorable product mix.

• Strategic investments are expected to drive long-term operational efficiency and innovation, with benefits anticipated in coming quarters.

• Management expects positive long-term impact from recent large PCB tenders and ongoing facility expansion.

• No specific guidance for 2025 provided.

• Demand is not a concern; operational issues are the main challenge for the next 1-2 years.